deferoxamine has been researched along with Marchiafava-Micheli Syndrome in 5 studies
Deferoxamine: Natural product isolated from Streptomyces pilosus. It forms iron complexes and is used as a chelating agent, particularly in the mesylate form.
desferrioxamine B : An acyclic desferrioxamine that is butanedioic acid in which one of the carboxy groups undergoes formal condensation with the primary amino group of N-(5-aminopentyl)-N-hydroxyacetamide and the second carboxy group undergoes formal condensation with the hydroxyamino group of N(1)-(5-aminopentyl)-N(1)-hydroxy-N(4)-[5-(hydroxyamino)pentyl]butanediamide. It is a siderophore native to Streptomyces pilosus biosynthesised by the DesABCD enzyme cluster as a high affinity Fe(III) chelator.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To report a case of acute bilateral central serous retinopathy associated with deferoxamine therapy in the context of paroxysmal nocturnal hemoglobinuria." | 7.83 | Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine. ( Giasin, O; Kaneshyogan, H; Makrygiannis, G; Sian, IS; Vahdani, K, 2016) |
| "To report a case of acute bilateral central serous retinopathy associated with deferoxamine therapy in the context of paroxysmal nocturnal hemoglobinuria." | 3.83 | Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine. ( Giasin, O; Kaneshyogan, H; Makrygiannis, G; Sian, IS; Vahdani, K, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Vahdani, K | 1 |
| Makrygiannis, G | 1 |
| Kaneshyogan, H | 1 |
| Sian, IS | 1 |
| Giasin, O | 1 |
| Nakakuma, H | 1 |
| Mey, U | 1 |
| Althoff, H | 1 |
| Tejero Lamarca, J | 1 |
| Yangüela Terroba, J | 1 |
| Diáz-Flores, L | 1 |
2 reviews available for deferoxamine and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
[Attractiveness of paroxysmal nocturnal hemoglobinuria for study].
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Deferoxamine; Haptoglobin | 2008 |
[Foundations of the diagnosis and therapy of hemolytic anemias].
Topics: Agglutinins; Anemia, Hemolytic; Antigens; Autoimmune Diseases; Blood Protein Disorders; Blood Transf | 1978 |
3 other studies available for deferoxamine and Marchiafava-Micheli Syndrome
| Article | Year |
|---|---|
Bilateral central serous retinopathy in a patient with paroxysmal nocturnal hemoglobinuria treated with deferoxamine.
Topics: Central Serous Chorioretinopathy; Deferoxamine; Fluorescein Angiography; Fundus Oculi; Hemoglobinuri | 2016 |
[Effect of desferrioxamine B on tissue sections of hemosiderosis of the kidney].
Topics: Adrenal Glands; Adult; Blood Transfusion; Buffers; Cortisone; Deferoxamine; Fats; Hemoglobinuria, Pa | 1966 |
[Nocturanl paroxysmal hemoglobinuria. II. Renal insufficiency in the course of the same (clinical, histological and ultramicroscopic study of the renal pathology and of its development after desferrioxamine therapy)].
Topics: Acute Kidney Injury; Biopsy; Deferoxamine; Female; Hemoglobinuria, Paroxysmal; Humans; Injections, I | 1973 |